B. Metzler seel. Sohn & Co. AG Sells 70,317 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

B. Metzler seel. Sohn & Co. AG decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 403,081 shares of the healthcare conglomerate's stock after selling 70,317 shares during the period. UnitedHealth Group comprises approximately 2.1% of B. Metzler seel. Sohn & Co. AG's investment portfolio, making the stock its 11th biggest holding. B. Metzler seel. Sohn & Co. AG's holdings in UnitedHealth Group were worth $203,961,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at about $25,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $32,000. Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at $40,000. Finally, DecisionPoint Financial LLC increased its position in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after buying an additional 62 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm's stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.33% of the company's stock.

Remove Ads

UnitedHealth Group Trading Up 4.1 %

Shares of UNH traded up $21.56 during mid-day trading on Thursday, reaching $544.76. 3,078,050 shares of the company were exchanged, compared to its average volume of 4,231,312. The stock has a market capitalization of $498.30 billion, a PE ratio of 35.15, a PEG ratio of 1.37 and a beta of 0.62. The business has a 50 day simple moving average of $509.15 and a two-hundred day simple moving average of $542.83. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company's quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the firm posted $5.83 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.54%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. Barclays dropped their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens boosted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research report on Thursday, December 5th. Finally, KeyCorp reiterated an "overweight" rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.